Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Moodys
Dow
Express Scripts

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017830

See Plans and Pricing

« Back to Dashboard

NDA 017830 describes LODOSYN, which is a drug marketed by Aton and is included in one NDA. It is available from two suppliers. Additional details are available on the LODOSYN profile page.

The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carbidopa profile page.
Summary for 017830
Tradename:LODOSYN
Applicant:Aton
Ingredient:carbidopa
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017830
Suppliers and Packaging for NDA: 017830
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LODOSYN carbidopa TABLET;ORAL 017830 NDA Aton Pharma, Inc 25010-711 25010-711-15 100 TABLET in 1 BOTTLE (25010-711-15)
LODOSYN carbidopa TABLET;ORAL 017830 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-200 68682-200-25 100 TABLET in 1 BOTTLE (68682-200-25)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017830

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Moodys
Boehringer Ingelheim
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.